Anthrax toxin: a tripartite lethal combination

被引:108
作者
Ascenzi, P
Visca, P
Ippolito, G
Spallarossa, A
Bolognesi, M
Montecucco, C
机构
[1] Univ Roma Tre, Dept Biol, I-00146 Rome, Italy
[2] Univ Roma Tre, Interdepartmental Lab Electron Microscopy, I-00146 Rome, Italy
[3] Dept Expt Biomed Sci, I-35131 Padua, Italy
[4] Univ Genoa, Ctr Excellence Biomed Res, I-16146 Genoa, Italy
[5] Univ Genoa, Natl Inst Phys Matter, Dept Phys, I-16146 Genoa, Italy
[6] IRCCS, Natl Inst Infect Dis, I-00149 Rome, Italy
关键词
anthrax toxin; edema factor; lethal factor; protective antigen; Bacillus anthracis;
D O I
10.1016/S0014-5793(02)03609-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anthrax is a severe bacterial infection that occurs when Bacillus anthracis spores gain access into the body and germinate in macrophages, causing septicemia and toxemia. Anthrax toxin is a binary A-B toxin composed of protective antigen (PA), lethal factor (LF), and edema factor (EF). PA mediates the entry of either LF or EF into the cytosol of host cells. LF is a zinc metalloprotease that inactivates mitogen-activated protein kinase kinase inducing cell death, and EF is an adenylyl cyclase impairing host defences. Inhibitors targeting different steps of toxin activity have recently been developed. Anthrax toxin has also been exploited as a therapeutic agent against cancer. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:384 / 388
页数:5
相关论文
共 48 条
  • [1] Anthrax toxin
    Bhatnagar, R
    Batra, S
    [J]. CRITICAL REVIEWS IN MICROBIOLOGY, 2001, 27 (03) : 167 - 200
  • [2] Identification of the cellular receptor for anthrax toxin
    Bradley, KA
    Mogridge, J
    Mourez, M
    Collier, RJ
    Young, JAT
    [J]. NATURE, 2001, 414 (6860) : 225 - 229
  • [3] Bacillus anthracis and antibacterial agents
    Bryskier, A
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (08) : 467 - 478
  • [4] Quickening the pace of anthrax research: three advances point towards possible therapies
    Chaudry, GJ
    Moayeri, M
    Liu, SH
    Leppla, SH
    [J]. TRENDS IN MICROBIOLOGY, 2002, 10 (02) : 58 - 62
  • [5] Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen
    Cunningham, K
    Lacy, DB
    Mogridge, J
    Collier, RJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) : 7049 - 7053
  • [6] Anthrax
    Dixon, TC
    Meselson, M
    Guillemin, J
    Hanna, PC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11) : 815 - 826
  • [7] Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin
    Drum, CL
    Yan, SZ
    Bard, J
    Shen, YQ
    Lu, D
    Soelaiman, S
    Grabarek, Z
    Bohm, A
    Tang, WJ
    [J]. NATURE, 2002, 415 (6870) : 396 - 402
  • [8] Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor
    Duesbery, NS
    Webb, CP
    Leppla, SH
    Gordon, VM
    Klimpel, KR
    Copeland, TD
    Ahn, NG
    Oskarsson, MK
    Fukasawa, K
    Paull, KD
    Vande Woude, GF
    [J]. SCIENCE, 1998, 280 (5364) : 734 - 737
  • [9] Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways
    Duesbery, NS
    Resau, J
    Webb, CP
    Koochekpour, S
    Koo, HM
    Leppla, SH
    Woude, GFV
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (07) : 4089 - 4094
  • [10] Penetration of protein toxins into cells
    Falnes, PO
    Sandvig, K
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (04) : 407 - 413